Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)

Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Synageva Biopharma Corp (NASDAQ:TRMS). According to a filing with the SEC, Baker Bros. Advisors now owns 20.48 million shares of ACADIA Pharmaceuticals, versus 19.96 million shares held at the end of the fourth quarter. The current stake amasses 21.0% of the ACADIA’s common stock.

The stake has been upped under a public offering of common stock, the fund purchasing around 526,300 shares. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) conducted a public offering of 6.4 million shares  at a price of $28.50 per share. A 30-day option to purchase up to 960,000 shares of common stock of ACADIA has also been granted to the underwriters. The net proceeds from the offering, which are expected to amount to $182.4 million will be used to fund ongoing and new clinical trials, in the development and commercialization efforts for pimavanserin, for its other product candidates and for general corporate purposes.

Baker Bros. also revealed holding warrants for acquisition of common stock of ACADIA, which if exercised, will result in an aggregate of almost 2.0 million shares.

 

ACADIA Pharmaceuticals Inc. (ACAD)

Dr. Stephen R. Biggar an employee of Baker Bros. serves on the Board of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Mr. Biggar holds 12,500 options to purchase common stock of ACADIA Pharmaceuticals at a price of $17.01 per share expiring June 7, 2023. Stephen Biggar might also get additional securities as compensation for his service on the Board.

Of all the hedge funds we track, Baker Bros. Advisors is the largest shareholder of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Peter Kolchinsky’s  Ra Capital Management, is also long ACADIA and holds 1.17 million shares, with a reported value of $29.24 million.

In a separate filing Baker Bros. Advisors revealed that it purchased 375,000 shares of Synageva Biopharma Corp (NASDAQ:TRMS) at a price of $105.75 per share and now holds around 8.2 million shares.

Synageva Biopharma Corp (NASDAQ:TRMS) has also recently announced a public offering of  2.0 million shares at a price of $105.75 per share. Morever, the company has granted a 30-day option to the underwriters to purchase an additional 300,000 shares of common stock.

Baker Bros. focuses on biotechnology companies. A couple of months ago, Baker Bros. Advisors trimmed its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,500 shares, from 1,130,317 shares held earlier. Earlier in January, Baker Bros. also revealed owning 13.84 million shares of Genomic Health, Inc. (NASDAQ:GHDX), of which it received 4,100 shares against director retainer fees of $10,000

Baker Bros. Advisors has 12.99% of its equity portfolio invested in Pharmacyclics, Inc. (NASDAQ:PCYC) a clinical-stage biopharmaceutical company, the stake amassing 8.72 million shares worth $922.32 million. The second largest holding of Baker Bros. is Seattle Genetics, Inc. (NASDAQ:SGEN), a company that focuses on the development and commercialization of monoclonal antibody-based therapies for cancer, in which the fund owns around 20.7 million shares.

Disclosure: none

Recommended Reading:

Hound Partners & Arrow Capital Management Are Buying the Same Stocks

Sandell Asset Management Increases Holding of Bob Evans Farms Inc (BOBE) Shares

Steven Cohen’s SAC Capital Ups Passive Stake in Gogo Inc (GOGO)

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!